Associated Papers
Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
Perera SD et al.
Current Opinion in Lipidology, 2024
Expanding the genetic spectrum for Chinese familial hypercholesterolemia population with six genetic mutations identified using a next-generation sequencing-based laboratory-developed screening test.
Jingxin S et al.
Molecular Genetics & Genomic Medicine, 2022
Genetic architecture of cardiometabolic risks in people living with HIV.
Cheng H et al.
Bmc Medicine, 2020
33109212 (PubMed )
Supplement: 12916_2020_1762_MOESM2_ESM.xlsx › Trig_EA
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.
Zhou Y et al.
Journal of Lipid Research, 2018
30076208 (PubMed )
Supplement: 10.1194_P086710_jlr.P086710-2.xlsx › CARDIoGRAM
Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels.
Jasim AA et al.
Frontiers in Genetics, 2018
SNPs in microRNA target sites and their potential role in human disease.
Moszyńska A et al.
Open Biology, 2017
Associations of triglyceride levels with longevity and frailty: A Mendelian randomization analysis.
Liu Z et al.
Scientific Reports, 2017
An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site.
Caussy C et al.
American Journal of Human Genetics, 2014
Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.
Li S et al.
Plos One, 2014
Select a paper to view details